Worldwide distribution, associated factors, and trends of gallbladder cancer : A global country-level analysis
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved..
This study aimed to evaluate the global distribution, associated factors, and epidemiologic trends of gallbladder cancer (GBC) by country, sex, and age groups. The Global Cancer Observatory was interrogated for the disease burden of GBC using age-standardized rates (ASR). The prevalence of different potential risk factors for each country was extracted from Global Health Observatory and their associations with GBC incidence and mortality were examined by linear regression analysis using beta coefficients (β). The Cancer Incidence in Five Continents I-XI and the WHO Mortality database were searched and Average Annual Percent Change (AAPC) was generated from joinpoint regression analysis. The incidence (ASR = 2.3) and mortality (ASR = 1.7) of GBC varied globally in 2018 and were higher in more developed countries and among females. Countries with higher incidence had higher human development index (βmale = 0.37; βfemale = 0.27), gross domestic products (βmale = 0.13) and higher prevalence of current smoking (βfemale = 0.05), overweight (βmale = 0.02), obesity (βmale = 0.03), and hypercholesterolaemia (βmale = 0.07). Similar patterns of associations were also observed for mortality with an additional association found for diabetes (βfemale = 0.07). Although there was an overall decreasing trend in mortality, an increasing trend in incidence was observed among some populations, particularly in males (AAPCs, 8.97 to 1.92) and in younger individuals aged <50 years (AAPCs, 12.02 to 5.66). The incidence of GBC varied between countries and was related to differences in the prevalence of potential risk factors. There was an increasing incidence trend among males and younger individuals. More intensive lifestyle modifications and disease surveillance are recommended for these populations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:521 |
|---|---|
| Enthalten in: |
Cancer letters - 521(2021) vom: 10. Sept., Seite 238-251 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huang, Junjie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cholecyst |
|---|
| Anmerkungen: |
Date Revised 20.02.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.canlet.2021.09.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330490648 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330490648 | ||
| 003 | DE-627 | ||
| 005 | 20240222091122.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.canlet.2021.09.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1301.xml |
| 035 | |a (DE-627)NLM330490648 | ||
| 035 | |a (NLM)34506845 | ||
| 035 | |a (PII)S0304-3835(21)00447-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huang, Junjie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Worldwide distribution, associated factors, and trends of gallbladder cancer |b A global country-level analysis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a This study aimed to evaluate the global distribution, associated factors, and epidemiologic trends of gallbladder cancer (GBC) by country, sex, and age groups. The Global Cancer Observatory was interrogated for the disease burden of GBC using age-standardized rates (ASR). The prevalence of different potential risk factors for each country was extracted from Global Health Observatory and their associations with GBC incidence and mortality were examined by linear regression analysis using beta coefficients (β). The Cancer Incidence in Five Continents I-XI and the WHO Mortality database were searched and Average Annual Percent Change (AAPC) was generated from joinpoint regression analysis. The incidence (ASR = 2.3) and mortality (ASR = 1.7) of GBC varied globally in 2018 and were higher in more developed countries and among females. Countries with higher incidence had higher human development index (βmale = 0.37; βfemale = 0.27), gross domestic products (βmale = 0.13) and higher prevalence of current smoking (βfemale = 0.05), overweight (βmale = 0.02), obesity (βmale = 0.03), and hypercholesterolaemia (βmale = 0.07). Similar patterns of associations were also observed for mortality with an additional association found for diabetes (βfemale = 0.07). Although there was an overall decreasing trend in mortality, an increasing trend in incidence was observed among some populations, particularly in males (AAPCs, 8.97 to 1.92) and in younger individuals aged <50 years (AAPCs, 12.02 to 5.66). The incidence of GBC varied between countries and was related to differences in the prevalence of potential risk factors. There was an increasing incidence trend among males and younger individuals. More intensive lifestyle modifications and disease surveillance are recommended for these populations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cholecyst | |
| 650 | 4 | |a Incidence | |
| 650 | 4 | |a Malignancy | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Temporal pattern | |
| 700 | 1 | |a Patel, Harsh K |e verfasserin |4 aut | |
| 700 | 1 | |a Boakye, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Chandrasekar, Viveksandeep Thoguluva |e verfasserin |4 aut | |
| 700 | 1 | |a Koulaouzidis, Anastasios |e verfasserin |4 aut | |
| 700 | 1 | |a Lucero-Prisno Iii, Don Eliseo |e verfasserin |4 aut | |
| 700 | 1 | |a Ngai, Chun Ho |e verfasserin |4 aut | |
| 700 | 1 | |a Pun, Ching Nei |e verfasserin |4 aut | |
| 700 | 1 | |a Bai, Yijun |e verfasserin |4 aut | |
| 700 | 1 | |a Lok, Veeleah |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Xianjing |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Jinqiu |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Wanghong |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, Zhi-Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Martin Cs |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer letters |d 1976 |g 521(2021) vom: 10. Sept., Seite 238-251 |w (DE-627)NLM000147273 |x 1872-7980 |7 nnns |
| 773 | 1 | 8 | |g volume:521 |g year:2021 |g day:10 |g month:09 |g pages:238-251 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.canlet.2021.09.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 521 |j 2021 |b 10 |c 09 |h 238-251 | ||